Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Reviews
Nature Immunology
Nature Cell Biology
Nature Genetics
news@nature.com
Nature Conferences
Dissect Medicine
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Article
Nature Medicine  8, 620 - 624 (2002)
doi:10.1038/nm0602-620

CNTF is a major protective factor in demyelinating CNS disease: A neurotrophic cytokine as modulator in neuroinflammation

Ralf A. Linker1, Mathias Mäurer1, Stefanie Gaupp1, Rudolf Martini2, Bettina Holtmann3, Ralf Giess1, Peter Rieckmann1, Hans Lassmann4, Klaus V. Toyka1, Michael Sendtner3 & Ralf Gold1

1  Clinical Research Group for Multiple Sclerosis, Department of Neurology, Julius-Maximilians-Universität Würzburg, Würzburg, Germany

2  Section of Developmental Neurobiology, Department of Neurology, Julius-Maximilians-Universität Würzburg, Würzburg, Germany

3  Department of Clinical Neurobiology, Julius-Maximilians-Universität, Würzburg, Germany

4  Brain Research Institute, Vienna, Austria

Correspondence should be addressed to Ralf Gold r.gold@mail.uni-wuerzburg.de
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS)1. So far, immunological mechanisms responsible for demyelination have been the focus of interest2. However, mechanisms regulating axon maintenance as well as glial precursor-cell proliferation and oligodendrocyte survival might also influence disease outcome3. The cytokine ciliary neurotrophic factor (CNTF), which was originally identified as a survival factor for isolated neurons, promotes differentiation, maturation and survival of oligodendrocytes4, 5, 6. To investigate the role of endogenous CNTF in inflammatory demyelinating disease, we studied myelin oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis (EAE) in CNTF-deficient and wild-type C57BL/6 mice. Disease was more severe in CNTF-deficient mice and recovery was poor, with a 60% decrease in the number of proliferating oligodendrocyte precursor cells (OPCs) and a more than 50% increase in the rate of oligodendrocyte apoptosis. In addition, vacuolar dystrophy of myelin and axonal damage were more severe in CNTF-deficient mice. These specific pathological features could be prevented by treatment with an antiserum against tumor necrosis factor-alpha, suggesting that endogenous CNTF may counterbalance this effect of TNF-alpha (ref. 7). Here we identify a factor that modulates, in an inflammatory environment, glial cell survival and is an outcome determinant of EAE.

MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated

REFERENCE
Oligodendrocytes
Nature Encyclopaedia of Life Sciences
 See all 5 matches for Reference

REVIEWS
NEW CONCEPTS IN THE IMMUNOPATHOGENESIS OF MULTIPLE SCLEROSIS
Nature Reviews Neuroscience Review Article (01 Apr 2002)
 See all 10 matches for Reviews

NEWS AND VIEWS
Remembering MOG: Autoantibody mediated demyelination in multiple sclerosis?
Nature Medicine News and Views (01 Feb 1999)
The fine line between autoimmune and allergic encephalomyelitis
Nature Immunology News and Views (01 Mar 2001)
 See all 4 matches for News And Views

RESEARCH
LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival
Nature Medicine Article (01 Jun 2002)
 See all 19 matches for Research

 Top
Abstract
Previous | Next
Table of contents
Full textFull text
Download PDFDownload PDF
Send to a friendSend to a friend
Save this linkSave this link

naturejobs

Figures & Tables
Export citation
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Medicine
ISSN: 1078-8956
EISSN: 1546-170X
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | For authors | Online submission | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | Reprints and permissions | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©2002 Nature Publishing Group | Privacy policy